Smrity Upadhyay, M.B.B.S., M.D.
Health Sciences Assistant Clinical Professor
To see if Smrity Upadhyay is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
UC Davis Midtown Ambulatory Care Center
Ellison Ambulatory Care Center
4860 Y Street, Suite 2500
Sacramento, CA 95817
Philosophy of Care
I value patient-centered aprroach that includes empathy, understanding and evidence based practice. I prioritize building trust through open communication, ensuring each of my patients feel heard and valued.
Clinical Interests
Dr. Upadhyay is an Infectious DIsease specialist providing care for difference infectious conditions including bacterial, fungal and viral infections. She has special interest in treated Transplant or immunocompromising conditions related infectious diseases. She enjoys working with different teams to provide multidisciplinary care to the patients. She is passionate about working with trainees of all levels in both the inpatient and outpatient clinical settings.
Research/Academic Interests
Dr. Smrity is interested in improving the care of patients with infections through defining best practices using evidence-based medicine. Specifically, she is interested in the infections prevention and treatment for immunocompromised patients. She is passionate about teaching trainees at all levels and welcomes opportunities for education.
Division
Infectious Diseases
Medical School
M.B.B.S., Tribhuvan University, Institute of Medicine, Kathmandu, Nepal 2010
Internship
Internal Medicine, Creighton University, 2013-2014
Internship
Internal Medicine, Creighton University, 2014-2026
Fellowship
Infectious Diseases, Indiana University School of Medicine, 2016-2018
Chief Fellow, Department of Infectious Disease at Indiana University School of Medicine 2017-2018,
Poster of Distinction Award for Poster Presentation in DDW conference 2015,
BOOK CHAPTERS
1. Upadhyay S, Dahal S, Khanal N, Bhatt VR. Malignancy-related ascites: Diagnostic
and therapeutic strategies. In Horizons in cancer research.. Nova Science
Publishers. Vol . 56. P. 1-22
Upadhyay, S., Dahal, S., Khanal, N., & Bhatt, V. R. (2015). Malignancy-related ascites:
Diagnostic and therapeutic strategies. In Horizons in Cancer Research (Vol. 56, pp. 1-
21). Nova Science Publishers, Inc..
2. Dahal S, Bhatt VR, Upadhyay S, Silberstein PT. Heparin induced
thrombocytopenia. In BM (Ed). Reference Module in Biomedical Research.
Elsevier Inc. Chapter 05058.
https://www.sciencedirect.com/science/article/abs/pii/B97801280123830505
83?via%3Dihub
3. Dahal S, Upadhyay S, Khanal N, Bhatt VR. Heparin-Induced Thrombocytopenia:
Current Concepts and Emerging Roles of Fondaparinux. In Bell MG (Ed).
Thrombocytopenia: Epidemiology, Potential Complications and Emerging
Treatments. New York, USA: Nova Science Publishers, Inc; 2014. P.97-117.
https://www.scopus.com/record/display.uri?eid=2-s2.0-
84954350289&origin=inward&txGid=33e33827b11b5b4b8ae393c26e85ffcd
4. Khanal N., Upadhyay S., Siberstein P.T., Autoimmune Hemolytic Anemia,
Reference Module in Biomedical Sciences. Elsevier.2014 doi:10.1016/B978-0-12-
801238-3. 04863-7
PEER-REVIEWED JOURNAL ARTICLES
1. Yeleti R., Guglin M, Kashif S., Upadhyay S., et al. Fulminant myocarditis: CoVID or
not CoVID? Reinfection or co-infection. Future cardiology. 2021 Nov 17 (8): 1307-
1311. Epub 2021 Feb 22
Yeleti R, Guglin M, Saleem K, Adigopula SV, Sinha A, Upadhyay S, Everett JE, Ballut K,
Uppuluri S, Rao RA. Fulminant myocarditis: COVID or not COVID? Reinfection or co-
infection? Future Cardiol. 2021 Nov;17(8):1307-1311. doi: 10.2217/fca-2020-0237.
Epub 2021 Feb 22. PMID: 33615872; PMCID: PMC7919708.
2. Upadhyay S., Dahal S., Bhatt VR., Khanal N., Silberstein P.T. Chemotherapy use in
Stage III Colon Cancer; a National Cancer Database Analysis. Therapeutic
Advances in medical Oncology. 2015
Upadhyay S, Dahal S, Bhatt VR, Khanal N, Silberstein PT. Chemotherapy use in stage III
colon cancer: a National Cancer Database analysis. Ther Adv Med Oncol. 2015
Sep;7(5):244-51. doi: 10.1177/1758834015587867. PMID: 26327922; PMCID:
PMC4543852.
3. Upadhyay S., Khanal N., Silberstein P.T. Colon Cancer and Emerging therapies.
Fred prac. 2015.
Khanal N, Upadhyay S, Silberstein PT. Colorectal Carcinoma and Emerging Targeted
Therapies. Fed Pract. 2015 Aug;32(Suppl 7):27S-31S. PMID: 30766127; PMCID:
PMC6375427.
4. Upadhyay S., Hamdeh S., Khanal N., Lanspa S. Bowel perforation after treatment
with sorafenib: a case report and review of literature. J Gastrointest Cancer. 2015
Jul 30
Hamdeh, S., Upadhyay, S., Khanal, N. et al. Bowel Perforation After Treatment
with Sorafenib: A Case Report and Review of Literature. J Gastrointest Canc 47,
420–422 (2016). https://doi.org/10.1007/s12029-015-9752-x
5. Khanal N, Dahal S, Upadhyay S, Bhatt VR, Bierman PJ. Differentiating malignant
hypertension-induced thrombotic microangiopathy from thrombotic
thrombocytopenic purpura. Therapeutic Advances in Hematology.
2015:2040620715571076.
Khanal N, Dahal S, Upadhyay S, Bhatt VR, Bierman PJ. Differentiating malignant
hypertension-induced thrombotic microangiopathy from thrombotic
thrombocytopenic purpura. Ther Adv Hematol. 2015 Jun;6(3):97-102. doi:
10.1177/2040620715571076. PMID: 26137201; PMCID: PMC4480518.
6. Khanal N, Upadhyay S, Dahal S, Bhatt VR, Silberstein PT. Systemic therapy in
stage IV pancreatic cancer: a population-based analysis using the National
Cancer Data Base. Therapeutic Advances in Medical Oncology.
2015:1758834015579313.
Khanal N, Upadhyay S, Dahal S, Bhatt VR, Silberstein PT. Systemic therapy in stage IV
pancreatic cancer: a population-based analysis using the National Cancer Data Base.
Ther Adv Med Oncol. 2015 Jul;7(4):198-205. doi: 10.1177/1758834015579313. PMID:
26136851; PMCID: PMC4480523.
7. Dhakal P, Bhatt VR, Upadhyay S, Khanal N, Ganti AK. Exertional chest pain and
dyspnea from hyperviscosity syndrome related to marginal zone lymphoma.
World J Oncol. 2014 Aug;5(4):175-177.
Dhakal P, Bhatt VR, Upadhyay S, Khanal N, Ganti AK. Exertional Chest
Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal
Zone Lymphoma. World J Oncol. 2014 Aug;5(4):175-177. doi:
10.14740/wjon837w. Epub 2014 Aug 25. PMID: 29147398; PMCID:
PMC5649743.
8. Khanal N, Giri S, Upadhyay S, Shostrom VK, Pathak R, Bhatt VR. Risk of second
primary malignancies and survival of adult patients with polycythemia vera: A
United States population-based retrospective study. Leuk Lymphoma. 2016
Jan;57(1):129-33.
Khanal N, Giri S, Upadhyay S, Shostrom VK, Pathak R, Bhatt VR. Risk of second
primary malignancies and survival of adult patients with polycythemia vera: A United
States population-based retrospective study. Leuk Lymphoma. 2016;57(1):129-33. doi:
10.3109/10428194.2015.1071492. Epub 2015 Sep 1. PMID: 26159045.
9. Mahfood Haddad T, Nawaz MS, Abuzaid AS, Upadhyay S, Bellamkonda P, Mooss
AN. Probable hydrochlorothiazide-induced myopericarditis: first case reported.
Case Rep Med. 2015;2015:319086.
Mahfood Haddad T, Nawaz MS, Abuzaid AS, Upadhyay S, Bellamkonda P, Mooss AN.
Probable hydrochlorothiazide-induced myopericarditis: first case reported. Case Rep
Med. 2015;2015:319086. doi: 10.1155/2015/319086. Epub 2015 Mar 15. PMID:
25861276; PMCID: PMC4377349.
10. Dahal S. Upadhyay S., Banjade R., Khanal N , Bhatt VR. Thrombocytopenia in
patients with chronic hepatitis C virus infection. Mediterr J Hematol Infect Dis
2017: vol 9
Dahal S, Upadhyay S, Banjade R, Dhakal P, Khanal N, Bhatt VR. Thrombocytopenia in
Patients with Chronic Hepatitis C Virus Infection. Mediterr J Hematol Infect Dis. 2017
Mar 1;9(1):e2017019. doi: 10.4084/MJHID.2017.019. PMID: 28293407; PMCID:
PMC5333732.